Bucladesine

Bucladesine structural formula

CAS Number362-74-3
Molecular FormulaC18H24N5O8P
Molecular Weight469.391
InChI KeyCJGYSWNGNKCJSB-YVLZZHOMSA-N
LogP0.249
Synonyms
  • Bucladesine
  • (4aR,6R,7R,7aR)-6-(6-Butanamido-9H-purin-9-yl)-2-hydroxy-2-oxotetrahydro-2H,4H-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate
  • Butanoic acid, (4aR,6R,7R,7aR)-tetrahydro-2-hydroxy-2-oxido-6-[6-[(1-oxobutyl)amino]-9H-purin-9-yl]-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-7-yl ester
  • 362-74-3
  • dibutyryl cAMP (DBA) (Dibutyryl Cyclic Adenosine Monophosphate) (Bucladesine)
  • Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate
  • 3',5'-Cyclic AMP dibutyrate
  • Actosin
  • Bucladesin
  • bucladesina
  • Butyramide, N-(9-?-D-ribofuranosyl-9H-purin-6-yl)-, 2'-butyrate, cyclic 3',5'-phosphate
  • Butyramide, N-(9-?-D-ribofuranosyl-9H-purin-6-yl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butyrate
  • Cyclic AMP dibutyrate
  • Cyclic AMP N6,2'-O-dibutyrate
  • Cyclic dibutyryl-AMP
  • Dibutyryl 3',5'-cyclic adenosine monophosphate
  • Dibutyryl 3',5'-cyclic AMP
  • Dibutyryl cAMP
  • Dibutyryl cyclic 3',5'-adenylic acid
  • Dibutyryl cyclic 3',5'-AMP
  • Dibutyryl cyclic adenosine 3',5'-monophosphate
  • Dibutyryl cyclic adenosine monophosphate
  • Dibutyryl cyclic AMP
  • Dibutyryl-3',5'-adenosine monophosphate
  • Dibutyryl-3',5'-AMP
  • Dibutyryladenosine 3',5'-cyclic monophosphate
  • Dibutyryladenosine 3',5'-cyclic phosphate
  • Dibutyryladenosine 3',5'-cyclophosphate
  • Dibutyryladenosine 3',5'-monophosphate
  • Dibutyryladenosine cyclic 3',5'-monophosphate
  • Dibutyryladenosine cyclic monophosphate
  • N6,2'-Dibutyryladenosine cyclic 3',5'-(hydrogen phosphate)
  • N6,2'-O-Dibutyryl 3',5'-cyclic adenosine monophosphate
  • N6,2'-O-Dibutyryl cAMP
  • N6,2'-O-Dibutyryl cyclic 3',5'-adenosine monophosphate
  • N6,2'-O-Dibutyryl cyclic 3',5'-AMP
  • N6,2'-O-Dibutyryl cyclic AMP
  • N6,2'-O-Dibutyryladenosine 3',5'-monophosphate
  • N6,2'-O-Dibutyryladenosine cyclic 3',5'-monophosphate
  • N6,2'-O-Dibutyryladenosine cyclic 3',5'-phosphate
  • N6,O2'-Dibutyryl 3',5'-AMP
  • N6,O2'-Dibutyryl adenosine 3',5'-cyclic monophosphate
  • N6,O2'-Dibutyryl adenosine-3',5'-phosphate
  • N6,O2'-Dibutyryl cyclic 3',5'-AMP
  • N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphate
  • N6,O2'-Dibutyryl cyclic adenosine 3',5'-monophosphoric acid
  • N6,O2'-Dibutyryl cyclic adenosine monophosphate
  • N6,O2'-Dibutyryl cyclic AMP
  • N6,O2'-Dibutyryl-3',5'-cyclic AMP
  • N6,O2'-Dibutyryladenosine 3',5'-monophosphate
  • N6,O2'-Dibutyryladenosine cyclic 3',5'-phosphate
  • N6,O2'-Dibutyryl-cAMP
  • N6,O2'-Dibutyrylcyclic adenosine 3',5'-phosphate
  • N-6-2-O-Dibutyryl adenosine-3',5'-monophosphate
  • N6-2'-O-Dibutyryl-3',5'-AMP
  • NSC 143108
  • AMP, cyclic dibutyryl
  • AMP N6-2'-O-dibutyrate
  • BRN 0871714
  • Cyclic AMP N(sup 6),2'-O-dibutyrate
  • Cyclic dibutyryl AMP
  • Cyclic N6-dibutyryl-AMP
  • DBC-AMP
  • Dibutyl cyclic AMP
  • Dibutyryl acid, AMP
  • Dibutyryl adenosine cyclic monophosphate
  • Dibutyryl adenosine cyclic 3',5'-monophosphate
  • Dibutyryl adenosine 3',5'-cyclic phosphate
  • N6,O2'-Dibutyryl 3',5'-adenosine monophosphate
  • N6,O2-Dibutyryl-adenosine 3',5'-cyclic monophosphate
  • N6,2-O-Dibutyryladenosine 3',5'-cyclic monophosphate
  • N(6),O(2)'-Dibutyryladenosine-3',5'-monophosphate
  • N6,O2'-Dibutyrylcyclic AMP
  • Dibutyrylic cyclic AMP
  • EINECS 206-649-8
  • N(sup 6),2'-O-Dibutyryl cAMP
  • N(sup 6),2'-O-Dibutyryl cyclic AMP
  • N(sup 6),O(sup 2')-Dibutyryl cAMP
  • N(sup 6),O(sup 2')-Dibutyryl cyclic AMP
  • Bucladesinum
  • UNII-63X7MBT2LQ
  • N(6),2'-O-dibutyryl cAMP
  • N(6),2'-O-dibutyryl cyclic AMP
  • N(6),O(2')-dibutyryl adenosine 3',5'-cyclic monophosphate
  • N(6),O(2')-dibutyryl cAMP
  • N(6),O(2')-dibutyryl cyclic 3',5'-AMP
  • N(6),O(2')-dibutyryl cyclic AMP
  • N(6),O(2')-dibutyryl-3',5'-cyclic AMP
  • N(6),O(2')-dibutyryladenosine 3',5'-monophosphate
  • dibutyryl adenosine 3',5'-cyclic phosphate
  • dibutyryl adenosine 3',5'-monophosphate
  • dibutyryladenosine 3',5'-cyclic monophosphate

Applications:

Separation of Bucladesine on Newcrom R1 HPLC column

February 16, 2018
Separation of Bucladesine on Newcrom C18 HPLC column

Bucladesine can be analyzed by this reverse phase (RP) HPLC method with simple conditions. The mobile phase contains an acetonitrile (MeCN), water, and phosphoric acid. For Mass-Spec (MS) compatible applications the phosphoric acid needs to be replaced with formic acid. Smaller 3 µm particles columns available for fast UPLC applications. This liquid chromatography method is scalable and can be used for isolation impurities in preparative separation. It also suitable for pharmacokinetics.

Application Column

Newcrom R1

The Newcrom columns are a family of reverse-phase-based columns. Newcrom A, AH, B, and BH are all mixed-mode columns with either positive or negative ion-pairing groups attached to either short (25 Å) or long (100 Å) ligand chains. Newcrom R1 is a special reverse-phase column with low silanol activity.

Select options
Application Analytes:
Bucladesine
The result was obtained by a proprietary SIELC algorithm. It may deviate from the actual experimental data. The experimental data are available upon request. Contact us before ordering the column as there may be a more suitable column alternative by either e-mail: support@sielc.com or by phone: 847-229-2629.